TPG BIOTECH
TPG Biotech is part of the growth equity and venture investment platform of TPG, the global private investment firm. TPG Biotech targets investments in pharmaceutical discovery and development, medical technology, diagnostics, healthcare and pharmaceutical services, life sciences, as well as industrial applications of biotechnology. TPG Biotech has access to the broader resources of TPG.
TPG BIOTECH
Industry:
Biotechnology Finance Venture Capital
Founded:
2002-06-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Google Font API Amazon Google Maps GStatic Google Static Content Google Maps API Amazon Oregon Region Proofpoint UltraDNS Neustar
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Citdex
Citdex is a global multi-strategy applied venture Investment firm inexorably focused on innovative technologies and funds.
Founders Fund
Founders Fund is a venture capital firm investing in companies building revolutionary technologies.
Greenoaks Capital
Greenoaks is a global investment firm specializing in technology companies.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-03-01 | Carisma Therapeutics | TPG Biotech investment in Series B - Carisma Therapeutics | 12 M USD |
| 2021-01-07 | Carisma Therapeutics | TPG Biotech investment in Series B - Carisma Therapeutics | 47 M USD |
| 2020-10-22 | Azura Ophthalmics | TPG Biotech investment in Series C - Azura Ophthalmics | 20 M USD |
| 2020-06-09 | DNAnexus | TPG Biotech investment in Series G - DNAnexus | 100 M USD |
| 2020-04-27 | Avalyn Pharma | TPG Biotech investment in Series B - Avalyn Pharma | 35.5 M USD |
| 2019-04-24 | Satsuma Pharmaceuticals | TPG Biotech investment in Series B - Satsuma Pharmaceuticals | 62 M USD |
| 2019-04-02 | Fusion Pharmaceuticals | TPG Biotech investment in Series B - Fusion Pharmaceuticals | 105 M USD |
| 2019-02-06 | DNAnexus | TPG Biotech investment in Series F - DNAnexus | 68 M USD |
| 2019-01-01 | Trevi Therapeutics | TPG Biotech investment in Series C - Trevi Therapeutics | 10 M USD |
| 2018-08-01 | Trevi Therapeutics | TPG Biotech investment in Series C - Trevi Therapeutics | 10.53 M USD |